Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone Dexborneol injection in thrombolyzed acute ischemic stroke
ChiCTR2200059563Phase 4Not yet recruiting
- Sponsor
- Department of Neurology, Ruian People's Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of edaravone dexborneol in ischemic stroke (2 arms), sponsored by Department of Neurology, Ruian People's Hospital. Primary endpoint: Modified Rankin Scale score at 90 days. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200059563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059563.